27.06.2022 15:00:00

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RDUS, FSTX, ZEN, USAK

NEW YORK, June 27, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

logo (PRNewsfoto/Halper Sadeh LLP)

Radius Health, Inc. (NASDAQ: RDUS)'s sale to Gurnet Point Capital and Patient Square Capital. Under the terms of the merger agreement, Gurnet Point and Patient Square will acquire all of the outstanding shares of Radius for $10.00 per share in cash plus a Contingent Value Right of $1.00 per share payable upon TYMLOS® (abaloparatide) net sales reaching $300 million during any consecutive 12-month period prior to December 31, 2025. If you are a Radius shareholder, click here to learn more about your rights and options.  

F-star Therapeutics, Inc. (NASDAQ: FSTX)'s sale to invoX Pharma for $7.12 per share. If you are a F-star shareholder, click here to learn more about your rights and options.

Zendesk, Inc. (NYSE: ZEN)'s sale to Permira and Hellman & Friedman LLC for $77.50 per share. If you are a Zendesk shareholder, click here to learn more about your rights and options.  

USA Truck, Inc. (NASDAQ: USAK)'s sale to DB Schenker for $31.72 per share in cash. If you are a USA Truck shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investigation-notice-halper-sadeh-llp-investigates-rdus-fstx-zen-usak-301575337.html

SOURCE Halper Sadeh LLP

Nachrichten zu F-star Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu F-star Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!